Refractory IPA

1 clinical trials · Condition

Record	Firm	Date
Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) (NCT05238116)	Pulmocide Ltd	2022-06-14

Every clearance here is in the API, with alerts when new ones post.